Recurrent Pneumothorax after Etanercept Therapy in a Rheumatoid Arthritis Patient: A Case Report

The use of anti-tumor necrosis factor (anti-TNF) agents for rheumatoid arthritis (RA) patients who are refractory to disease-modifying anti-rheumatic drugs is gradually increasing. Etanercept is the first anti-TNF agent to be approved for RA treatment and is also the most widely used. However, aggra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sang Hoon, Choi, Sung Jae, Seo, Young Ho, Kim, Ji Hyoung, Jeong, Il Woo, Sohn, Sung Birm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276793/
https://www.ncbi.nlm.nih.gov/pubmed/25568848
http://dx.doi.org/10.4068/cmj.2014.50.3.115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276793/
https://www.ncbi.nlm.nih.gov/pubmed/25568848
http://dx.doi.org/10.4068/cmj.2014.50.3.115

Ejemplares similares